Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
Top Cited Papers
- 1 April 2001
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 7 (4) , 383-385
- https://doi.org/10.1038/86397
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Steering anti-cancer drugs away from the TRAILNature Medicine, 2000
- Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligandNature Medicine, 2000
- Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapyProceedings of the National Academy of Sciences, 2000
- A Unique Zinc-Binding Site Revealed by a High-Resolution X-ray Structure of Homotrimeric Apo2L/TRAILBiochemistry, 2000
- Locoregional Apo2L/TRAIL Eradicates Intracranial Human Malignant Glioma Xenografts in Athymic Mice in the Absence of NeurotoxicityBiochemical and Biophysical Research Communications, 1999
- Triggering Cell DeathMolecular Cell, 1999
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999
- Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivoNature Medicine, 1999
- Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine FamilyJournal of Biological Chemistry, 1996
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995